Search

everythinglearnresearchcommunity

for

Search:↓

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Improving dermal papilla cells can help regenerate hair follicles.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Higher hair follicle density leads to more wool in rabbits, influenced by specific genes and lncRNAs.

Exosome-based therapies show promise for treating alopecia areata but need more research.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

IL-15 helps hair grow longer and stronger by extending the growth phase and reducing cell death.

Melatonin affects gene expression in goat hair follicles, potentially increasing cashmere production.

Xinyang Tablet improves heart function in sepsis by reducing inflammation.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Blood metabolites significantly influence alopecia areata risk.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Targeting non-Smad pathways in TGF-β signaling may improve keloid treatment.

Gut bacteria differences could help diagnose and treat alopecia areata.

Extracellular vesicles from mammary cells help heal skin wounds effectively.

Arctium lappa L. might help treat immune-related skin diseases, but more research is needed.